Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ingevity (NGVT) Research & Development (2016 - 2025)

Ingevity (NGVT) has disclosed Research & Development for 10 consecutive years, with $7.4 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 13.85% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.9 million through Dec 2025, up 11.57% year-over-year, with the annual reading at $28.4 million for FY2025, 15.92% up from the prior year.
  • Research & Development for Q4 2025 was $7.4 million at Ingevity, up from $7.0 million in the prior quarter.
  • The five-year high for Research & Development was $8.8 million in Q1 2023, with the low at $800000.0 in Q4 2023.
  • Average Research & Development over 5 years is $6.9 million, with a median of $7.2 million recorded in 2022.
  • The sharpest move saw Research & Development tumbled 88.89% in 2023, then skyrocketed 712.5% in 2024.
  • Over 5 years, Research & Development stood at $7.0 million in 2021, then increased by 2.86% to $7.2 million in 2022, then crashed by 88.89% to $800000.0 in 2023, then surged by 712.5% to $6.5 million in 2024, then increased by 13.85% to $7.4 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $7.4 million, $7.0 million, and $7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.